MANUEL PRAGA TERENTE-rekin lankidetzan egindako argitalpenak (27)

2014

  1. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression

    Journal of Hypertension, Vol. 32, Núm. 10, pp. 2082-2091

2013

  1. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension

    Current Hypertension Reports, Vol. 15, Núm. 3, pp. 196-203

  2. Malignant hypertension in patients treated with vascular endothelial growth factor inhibitors

    Journal of Clinical Hypertension, Vol. 15, Núm. 3, pp. 215-216

2011

  1. Validation of a therapeutic scheme for the treatment of resistant hypertension

    Journal of the American Society of Hypertension, Vol. 5, Núm. 6, pp. 498-504

2010

  1. Long-term renal survival in malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 10, pp. 3266-3272

2007

  1. Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome?

    Journal of clinical hypertension (Greenwich, Conn.), Vol. 9, Núm. 8, pp. 595-600

2006

  1. Blood pressure control in patients with chronic renal insufficiency in Spain: A cross-sectional study

    Journal of Hypertension, Vol. 24, Núm. 2, pp. 395-402

  2. Chronic kidney disease as a situation of high added risk in hypertensive patients

    Journal of the American Society of Nephrology

2003

  1. Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 4, Núm. 1, pp. 43-47

1997

  1. L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 12, Núm. 7, pp. 1437-1440

1995

  1. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity

    Nephron, Vol. 70, Núm. 1, pp. 35-41

1994

  1. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension

    Kidney International, Supplement

1992

  1. Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake

    Journal of the American Society of Nephrology, Vol. 3, Núm. 6, pp. 1307-1311

1990

  1. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: A prospective randomized study

    Transplantation Proceedings

1988

  1. Clinical and histological sequence of recurrent focal segmental glomerulosclerosis.

    Nephron

  2. Cyclosporin in the treatment of steroid-resistant rejection in renal transplants

    Nefrologia, Vol. 8, Núm. SUPPL. 1, pp. 72-75

  3. Long-term enalapril therapy in Bartter's syndrome

    Nephron

1987

  1. Acyclovir therapy of severe chickenpox in an adult renal transplant patient

    Nephrology Dialysis Transplantation

  2. Fractional excretion of sodium represents as index of cyclosporine nephrotoxicity in the early post-transplant period

    Transplantation Proceedings, Vol. 19, Núm. 5, pp. 4005-4007

  3. Hemorragia pulmonar asociada a glomerulonefritis proliferativa extracapilar.

    Revista Clinica Espanola, Vol. 181, Núm. 2, pp. 68-74